Vuorio T[au] - Search Results

Year	Number of Results
1982	1
1984	3
1985	2
1987	2
1988	4
1989	4
1990	6
1991	3
2009	2
2011	1
2012	1
2014	2
2015	2
2016	1
2017	1
2018	2
2019	2
2020	2
2022	1
2023	1
2024	1

1

Cardiac Lymphatics - A New Avenue for Therapeutics?

Vuorio T, Tirronen A, Ylä-Herttuala S. Vuorio T, et al. Trends Endocrinol Metab. 2017 Apr;28(4):285-296. doi: 10.1016/j.tem.2016.12.002. Epub 2017 Jan 10. Trends Endocrinol Metab. 2017. PMID: 28087126 Review.

2

Recent advances in novel therapies for lipid disorders.

Tirronen A, Hokkanen K, Vuorio T, Ylä-Herttuala S. Tirronen A, et al. Among authors: vuorio t. Hum Mol Genet. 2019 Oct 1;28(R1):R49-R54. doi: 10.1093/hmg/ddz132. Hum Mol Genet. 2019. PMID: 31227825 Review.

3

The EDCMET Project: Metabolic Effects of Endocrine Disruptors.

Küblbeck J, Vuorio T, Niskanen J, Fortino V, Braeuning A, Abass K, Rautio A, Hakkola J, Honkakoski P, Levonen AL. Küblbeck J, et al. Among authors: vuorio t. Int J Mol Sci. 2020 Apr 24;21(8):3021. doi: 10.3390/ijms21083021. Int J Mol Sci. 2020. PMID: 32344727 Free PMC article. Review.

4

Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance T_RAFFn, T_1ρ and T₂ relaxation times.

Ylä-Herttuala E, Vuorio T, Kettunen S, Laidinen S, Ylä-Herttuala S, Liimatainen T. Ylä-Herttuala E, et al. Among authors: vuorio t. Sci Rep. 2023 Jan 28;13(1):1579. doi: 10.1038/s41598-023-28219-6. Sci Rep. 2023. PMID: 36709358 Free PMC article.

5

Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors.

Vuorio T, Jauhiainen S, Ylä-Herttuala S. Vuorio T, et al. Expert Opin Biol Ther. 2012 Jan;12(1):79-92. doi: 10.1517/14712598.2012.641011. Epub 2011 Nov 25. Expert Opin Biol Ther. 2012. PMID: 22115316 Review.

6

Control of type I collagen genes in scleroderma and normal fibroblasts.

de Crombrugghe B, Vuorio T, Karsenty G. de Crombrugghe B, et al. Among authors: vuorio t. Rheum Dis Clin North Am. 1990 Feb;16(1):109-23. Rheum Dis Clin North Am. 1990. PMID: 1689503 Review.

7

Experiences of patients with fibromyalgia at a Finnish Health Centre: A qualitative study.

Varinen A, Vuorio T, Kosunen E, Koskela TH. Varinen A, et al. Among authors: vuorio t. Eur J Gen Pract. 2022 Dec;28(1):157-164. doi: 10.1080/13814788.2022.2085683. Eur J Gen Pract. 2022. PMID: 35726620 Free PMC article.

8

Determinants of sickness absence rate among Finnish municipal employees.

Vuorio T, Suominen S, Kautiainen H, Korhonen P. Vuorio T, et al. Scand J Prim Health Care. 2019 Mar;37(1):3-9. doi: 10.1080/02813432.2019.1568710. Epub 2019 Jan 28. Scand J Prim Health Care. 2019. PMID: 30689483 Free PMC article.

9

Fibroblast activation in scleroderma.

Vuorio TK, Kähäri VM, Lehtonen A, Vuorio EI. Vuorio TK, et al. Scand J Rheumatol. 1984;13(3):229-37. doi: 10.3109/03009748409100391. Scand J Rheumatol. 1984. PMID: 6484539

10

Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals.

Attema B, Kummu O, Pitkänen S, Weisell J, Vuorio T, Pennanen E, Vorimo M, Rysä J, Kersten S, Levonen AL, Hakkola J. Attema B, et al. Among authors: vuorio t. Arch Toxicol. 2024 Mar;98(3):911-928. doi: 10.1007/s00204-023-03658-2. Epub 2024 Jan 5. Arch Toxicol. 2024. PMID: 38182912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year